GuideNephrology

Membranous nephropathy prognosis (Toronto model and KDIGO risk stratification)

Reading sheet on estimating the risk of kidney failure in primary membranous nephropathy from persistent proteinuria, kidney function and current markers.

Updated 3 November 2026

When to use it

Adults with primary membranous nephropathy (usually anti-PLA2R positive) after an observation period on supportive therapy, to decide whether to start immunosuppression.

Toronto model

Derived from the Toronto Glomerulonephritis Registry (184 patients) to predict chronic renal insufficiency (creatinine clearance ≤ 60 ml/min/1.73 m² sustained ≥ 12 months). Prognostic variables were:

• The highest proteinuria sustained over a 6-month period.

• Initial creatinine clearance.

• The slope (rate of change) of clearance over those 6 months.

It was validated in cohorts from Italy (101) and Finland (78) with accuracy ≥ 85%. The original equations are not reproduced here because their units and scales could not be verified.

Keep reading in the app

  • KDIGO 2021 risk stratification
  • Treatment implications
  • Limitations

Practical tip

Proteinuria at biopsy alone predicts poorly; what matters is the highest proteinuria sustained over 6 months, together with initial clearance and its slope.

2 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top